89Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma: Results from phase 3 ZIRCON study

This article has no abstract
Epistemonikos ID: ddda937fc62f547ad05fff0408eb566c71b4da88
First added on: Feb 19, 2025